Bull
$200.76
Precio del escenario
$159.840
+0.016 (+0.01%)Al cierre
Huron Consulting Group Inc. is a global professional service. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Its products include TriZetto’s Facets, QNXT, and HealthEdge solutions.
Huron Consulting Group Inc is a good buy right now due to its strong recent earnings performance, with Q2 2026 earnings per share reported at $2.46, exceeding estimates by 15.49%. Additionally, the forward P/E ratio of 17.57 suggests the stock is undervalued compared to its growth potential. The main risk is the recent insider selling, which has increased by 196.55%, indicating potential concerns among insiders about the stock's future performance.
Benchmark
$215
2026-06-23
Benchmark
2026-06-23
Precio objetivo
$215
Benchmark
$215
2025-12-24
Benchmark
2025-12-24
Precio objetivo
$215
Truist
$240
2025-11-14
Truist
2025-11-14
Precio objetivo
$240
Barrington
$190
2025-10-30
Barrington
2025-10-30
Precio objetivo
$190
Barrington
$176
2025-08-07
Barrington
2025-08-07
Precio objetivo
$176
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Huron Consulting Group Stock Buy Rank

Huron Consulting Reports Q2 Earnings Exceeding Expectations

Huron Consulting Group Reports Record Q2 2026 Earnings and Guidance Increase

Huron to Announce Q2 Financial Results on July 28, 2026

Huron Consulting Director Sells Shares Amid Market Weakness
Huron Consulting Group Inc. is a global professional service. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Its products include TriZetto’s Facets, QNXT, and HealthEdge solutions. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).
Huron Consulting Group Inc is a good buy right now due to its strong recent earnings performance, with Q2 2026 earnings per share reported at $2.46, exceeding estimates by 15.49%. Additionally, the forward P/E ratio of 17.57 suggests the stock is undervalued compared to its growth potential. The main risk is the recent insider selling, which has increased by 196.55%, indicating potential concerns among insiders about the stock's future performance.
4 analysts cover HURN: 2 rate it Buy, 2 Hold and 0 Sell. The average price target is 211.00.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.